CYP19A1 and central nervous system cancer: Previous studies carried out by Dave et al. [41] investigated the efficacy of the aromatase inhibitor, Letrozole, on GBM cell growth in vitro and in vivo exclusively in the conventional human glioma cell lines and the rat glioma C6 cells.